Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3VOM

Structure of a putative phosphoserine aminotransferase from mycobacterium tuberculosis

Summary for 3VOM
Entry DOI10.2210/pdb3vom/pdb
Related2FYF
DescriptorPutative phosphoserine aminotransferase, PYRIDOXAL-5'-PHOSPHATE, SULFATE ION, ... (5 entities in total)
Functional Keywordspsat, serc, plp-dependent enzyme, phosphoserine aminotransferase, transferase
Biological sourceMycobacterium tuberculosis
Total number of polymer chains2
Total formula weight86804.99
Authors
Coulibaly, F.,Lassalle, E.,Baker, H.M.,Baker, E.N. (deposition date: 2012-01-30, release date: 2012-02-22, Last modification date: 2023-11-08)
Primary citationCoulibaly, F.,Lassalle, E.,Baker, H.M.,Baker, E.N.
Structure of phosphoserine aminotransferase from Mycobacterium tuberculosis.
Acta Crystallogr.,Sect.D, 68:553-563, 2012
Cited by
PubMed Abstract: Mycobacterium tuberculosis (Mtb), the causative agent of TB, remains a serious world health problem owing to limitations of the available drugs and the emergence of resistant strains. In this context, key biosynthetic enzymes from Mtb are attractive targets for the development of new therapeutic drugs. Here, the 1.5 Å resolution crystal structure of Mtb phosphoserine aminotransferase (MtbPSAT) in complex with its cofactor, pyridoxal 5'-phosphate (PLP), is reported. MtbPSAT is an essential enzyme in the biosynthesis of serine and in pathways of one-carbon metabolism. The structure shows that although the Mtb enzyme differs substantially in sequence from other PSAT enzymes, its fold is conserved and its PLP-binding site is virtually identical. Structural comparisons suggest that this site remains unchanged throughout the catalytic cycle. On the other hand, PSAT enzymes are obligate dimers in which the two active sites are located in the dimer interface and distinct differences in the MtbPSAT dimer are noted. These impact on the substrate-binding region and access channel and suggest options for the development of selective inhibitors.
PubMed: 22525753
DOI: 10.1107/S0907444912004829
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon